Release 8.2 Release Notes

Release Date: November 13, 2020

Eviti Connect Enhancements

• Added a new formulary redirect drug configuration that displays a warning message and preferred drug after the user chooses a drug. The user can click the preferred drug to include in the treatment plan, or they can keep the drug that they originally chose (#95415 & #96678). This enhancement also includes the following updates:
  • Added validation to the Treatment Warning & Deviation (Brand and Generic) and Formulary Redirect configurations that prevents a payer from configuring more than one of these configurations for a drug (#96679).
  • Updated the Cost Savings dashboard. When a treatment plan includes a drug that is configured for Treatment Warning & Deviation (Brand or Generic) or Formulary Redirect, the system includes a Drug Warning link that the Medical Office team can click to get more details regarding the configuration (#96678).
  • Logs the user selection on the regimen search page for the Treatment Warning & Deviation (Brand and Generic) and Formulary Redirect pop up (#96952).
• Updated to the Multiple Payer Access User role to let the user authorize or decline appeals from the payer dashboard (#94829).

Knowledge Base Web Enhancements

• Policy Impact Excel (aka PIE Report): A new report in Workflow Management that will pull all of the data from newly created regimens or edited regimens that is used to analyze if the updates will need modifications to existing Medical Policy Rules or the creation of new rules (#95222).
• Updates to the Drug Justification Prompt: Provide users the ability to create prompts based on Cancer Type and Goal of Treatment (#94827). This enhancement also includes the following updates:
  • Updates to the Medical Policy View Tab to include the updates to the configuration (#96405).
  • Update reports to reflect the updates that were made to the Drug Justification Prompt (#96404).
  • Updates to the Drug Justification Prompt interface to include the following (#96779):
    • The addition of the Export to Excel the configured prompts.
    • Displaying the number of prompts at the top of the grid on the screen.
    • The removal of the following columns from the grid: GPI and Justification Template GPI.
    • The addition of a Last Modified By and Date column on the grid.
• Update Template Management to default the Treatment Goals Fields to not required (#96060).
• Updates to the ICD-10 Management page to allow the user to identify the leading letters for ICD-10 codes that can be uploaded and updated. This will allow us to expand beyond oncology-specific ICD-10 Codes (#96059).
• Medical Policy QA Report: Remove extra cells from Justification column (#97300).
• Add text to the Diagnosis Override and BioMarker Override Rules to provide clarity on how the rules are applied in Connect (#97117).
• Clinically Significant Report: Modify the Display (#97116).

IT Security Updates

• Upgrade JQuery in the following areas to version 1.9.1:
  • Connect (#91557)
  • Eviti.Security.Web (#91558)
  • KB Web (#91561)
• Upgrade Eviti.API Bootstrap to version 3.4.1 (#91560).
• Eviti Advisor 500 Errors surfacing to the user (#94735).

Resolved Issues

• Entrectinib doubling name on Drug Detail page (#94526).
• Unknown HCPC: Applicable HCPCs is not being saved with drugs (#96654).
• Preference footnote is not displayed on treatment plan summaries (#96747).
• Updates to the Alternative Regimen Search to prevent supportive care drugs that are configured for Treatment Warning & Deviation (Brand or Generic) or Formulary Redirect that are configured as Is Cannot Be Entered = True from impacting the search results (#98228).
• Retired RT codes are displayed on Plan Summaries when Temp/Service codes are selected (#98042).
• Remove Drug Justification Prompts configured for Supportive Care Drugs from the Medical Policy QA, Medical Policy Maintenance and Pathway UAT Reports (#97813).
• KB2: When viewing details for any drug, the original drug name is removed from the parent menu (#97160).
• Issue with Export to Excel functionality on Medical Policy Rules Management Screen (#97074).